	Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy. JMIR Res Protoc Aye PS, Barnes J, Laking G, Cameron L, Anderson M, Luey B, Delany S, Harris D, McLaren B, Brenman E, Wong J, Lawrenson R, Arendse M, Tin Tin S, Elwood M, Hope P, McKeage MJ. PMID: 38954434 [PubMed - indexed for MEDLINE]
	E-Cigarette Use and Lung Cancer Screening Uptake. JAMA Netw Open Wang Q, Jiang C, Hsu ML, Wisnivesky J, Dowlati A, Boffetta P, Kong CY. PMID: 38954419 [PubMed - indexed for MEDLINE]
	Repeated dynamic [(18)F]FDG PET/CT imaging using a high-sensitivity PET/CT scanner for assessing non-small cell lung cancer patients undergoing induction immuno-chemotherapy followed by hypo-fractionated chemoradiotherapy and consolidative immunotherapy: report from a prospective observational study (GASTO-1067). Eur J Nucl Med Mol Imaging Wang D, Mo Y, Liu F, Zheng S, Liu H, Li H, Guo J, Fan W, Qiu B, Zhang X, Liu H. PMID: 38953934 [PubMed - as supplied by publisher]
	Why do a lung biopsy for benign lesions? Minerva Surg Cardinale L, Basile D, Fraccalini T, Volpicelli G, Busso M. PMID: 38953756 [PubMed - indexed for MEDLINE]
	Added Value of a Robotic-assisted Bronchoscopy Platform in Cone Beam Computed Tomography-guided Bronchoscopy for the Diagnosis of Pulmonary Parenchymal Lesions. J Bronchology Interv Pulmonol Shaller BD, Duong DK, Swenson KE, Free D, Bedi H. PMID: 38953732 [PubMed - indexed for MEDLINE]
	Q&A: Barriers to testing for NTRK fusions in metastatic lung and thyroid cancer. Clin Adv Hematol Oncol Hong DS, Drilon A, Wirth LJ. PMID: 38953729 [PubMed - indexed for MEDLINE]
	Diagnosing NTRK fusions in lung and thyroid cancer. Clin Adv Hematol Oncol Hong DS. PMID: 38953726 [PubMed - indexed for MEDLINE]
	Efficacy and safety of NTRK inhibitors in patients with NTRK fusion-positive lung and thyroid cancers. Clin Adv Hematol Oncol Hong DS, Drilon A, Wirth LJ. PMID: 38953725 [PubMed - indexed for MEDLINE]
	Differential expression profiles and functional prediction of circular RNAs in lung cancer patients with chronic obstructive pulmonary disease: a pilot study. Gen Physiol Biophys Li X, Shen Y, Cheng J, Chen J, Yuan Z, Wang T, Chen L, Liu L, Wen F. PMID: 38953571 [PubMed - indexed for MEDLINE]
	The rapidly changing field of predictive biomarkers of non-small cell lung cancer. Pathol Oncol Res Tóth LJ, Mokánszki A, Méhes G. PMID: 38953007 [PubMed - indexed for MEDLINE]
	CT radiomics to differentiate neuroendocrine neoplasm from adenocarcinoma in patients with a peripheral solid pulmonary nodule: a multicenter study. Front Oncol Liu X, Li H, Wang S, Yang S, Zhang G, Xu Y, Yang H, Shan F. PMID: 38952551 [PubMed]
	Downregulation of DIP2B as a prognostic marker inhibited cancer proliferation and migration and was associated with immune infiltration in lung adenocarcinoma via CCND1 and MMP2. Heliyon Wu CY, Liu Z, Luo WM, Huang H, Jiang N, Du ZP, Wang FM, Han X, Ye GC, Guo Q, Chen JL. PMID: 38952374 [PubMed]
	Machine learning identifies prognostic subtypes of the tumor microenvironment of NSCLC. Sci Rep Yu D, Kane MJ, Koay EJ, Wistuba II, Hobbs BP. PMID: 38951567 [PubMed - indexed for MEDLINE]
	Comprehensive pan-cancer analysis reveals that C5orf34 regulates the proliferation and mortality of lung cancer. Funct Integr Genomics Yang M, Deng Y, Ma Y, Song C, Wu Z, Yibulayin X, Sun X, Guo Y, He D. PMID: 38951221 [PubMed - indexed for MEDLINE]
	A systematic review and dose-response meta-analysis of prospective cohort studies on coffee consumption and risk of lung cancer. Sci Rep Jabbari M, Salari-Moghaddam A, Bagheri A, Larijani B, Esmaillzadeh A. PMID: 38951141 [PubMed - indexed for MEDLINE]
	Role of drug-eluting bead bronchial arterial chemoembolisation in the treatment of non-small cell lung cancer: protocol for a meta-analysis. BMJ Open Yu G, Shen Y, Ye B, Xu X, Zhao W. PMID: 38951003 [PubMed - indexed for MEDLINE]
	Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial. Lancet Oncol Tendler S, Dunphy MP, Agee M, O'Donoghue J, Aly RG, Choudhury NJ, Kesner A, Kirov A, Mauguen A, Baine MK, Schoder H, Weber WA, Rekhtman N, Lyashchenko SK, Bodei L, Morris MJ, Lewis JS, Rudin CM, Poirier JT. PMID: 38950555 [PubMed - as supplied by publisher]
	Real-world clinical and economic outcomes for patients with advanced non-small cell lung cancer enrolled in a clinical trial following comprehensive genomic profiling via liquid biopsy. J Manag Care Spec Pharm Wiedower JA, Forbes SP, Tsai LJ, Liao J, Raez LE. PMID: 38950156 [PubMed - indexed for MEDLINE]
	Acceptability of adding a non-contrast abdominal CT scan to screen for kidney cancer and other abdominal pathology within a community-based CT screening programme for lung cancer: A qualitative study. PLoS One Usher-Smith JA, Masson G, Godoy A, Burge SW, Kitt J, Farquhar F, Cartledge J, Kimuli M, Burbidge S, Crosbie PAJ, Eckert C, Hancock N, Iball GR, Rogerson S, Rossi SH, Smith A, Simmonds I, Wallace T, Ward M, Callister MEJ, Stewart GD. PMID: 38950010 [PubMed - indexed for MEDLINE]
	Stratification of Lung Adenocarcinoma Patients Based on In Silico and Immunohistochemistry Analyses of Oxidative Stress-Related Genes. Cancer Biother Radiopharm Qiu C, Zhou Y, Xiao X, Song T, Zeng D, Peng J. PMID: 38949986 [PubMed - as supplied by publisher]

Articles 1 - 20 / 142884

Page 1 of 7145



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy